A-68 Yoga Therapy in Pediatric Epilepsy

Abstract Objective This pilot study examines the effects of yoga therapy on anxiety, depression symptoms, inattention, and seizure frequency in children diagnosed with Epilepsy. Data Selection The sample consisted of 5 participants (4 male, 1 female), ages 7-12 years old, with diagnoses of generalized epilepsy, absence epilepsy, and complex partial epilepsy. Participants all had average cognitive abilities (IQ SS = 100.7; VCI SS = 106.3; PRI SS = 108.3), a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), and clinically significant levels of anxiety and depression. Participants participated in 30-45-minute-long yoga sessions over a 6-week period with 2-3 home sessions each week. Differences in hyperactivity, anxiety, depression, and inattention were measured via parent rating Likert scales (0-poor, 10-best) at 1 month, 3 months, and 6 months. Participants also completed weekly self-report measures to assess anxiety and depression (Revised Children’s Manifest Anxiety, Second Edition (RCMAS-2) and Children’s Depression Inventory, Second Edition (CDI-2)). Data Synthesis No significant reliable change differences were found between sessions; however, a downward trend was visible in reduction of anxiety (RCMAS-2; first session M = 16.4, last session M = 9.4) and depression symptoms (CDI-2; first session M = 52.8, last session M = 49.2). Further, parents reported a decrease in anxiety (first session M = 4.8, last session M = 6.4). No seizures were reported during the study. Conclusions There is no previous research using pediatric populations and yoga therapy effects on reducing seizure frequency, anxiety, depression, and attention problems. This pilot study showed promising results in reducing anxiety, and depression symptoms. Limitations of study include small sample size and attrition, which are both important to consider when conducting another study.

Download Full-text

Anxiety and Depression among Hypertensive Outpatients in Afghanistan: A Cross-Sectional Study in Andkhoy City

International Journal of Hypertension ◽

10.1155/2018/8560835 ◽

2018 ◽

Vol 2018 ◽

pp. 1-8 ◽

Cited By ~ 5

Author(s):

Mohammad Shoaib Hamrah ◽

Mohammad Hassan Hamrah ◽

Hideki Ishii ◽

Susumu Suzuki ◽

Mohammad Hussain Hamrah ◽

...

Keyword(s):

Diabetes Mellitus ◽

Chronic Diseases ◽

National Level ◽

Depression Scale ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Cross Sectional ◽

Hypertensive Patients ◽

Comorbid Anxiety ◽

Anxiety Depression

There is a relationship between mental and physical health. Depression and anxiety are linked with the development of several chronic diseases. The purpose of the present study was to determine the prevalence and factors associated with anxiety and depression among adult hypertensive outpatients in Afghanistan. Methods. Two hundred thirty-four consecutive hypertensive patients from December 2015 to August 2016 were recruited to complete the Hospital Anxiety and Depression Scale (HADS) questionnaire, which has scores for classifying the participants having anxiety and depression symptoms. Results. Of the total 234 patients, 81 (34.6%) were males and 153 (65.4%) were females. The mean age was 54.6±12.7 for the hypertensive patients with anxiety and 63.8±15.0 for the hypertensive patients with depression while this figure was 49.5±10.2 for the adult participants in general population in Kabul city (Saeed, 2013). The prevalence of anxiety and depression (42.3% vs. 58.1%) among hypertensive persons is compared with the same mental disorders among Afghan refugees (39.3% vs. 22.1%) in Dalakee Refugee Camp (in Iran) (Hosseini Divkolaye and Burkle, 2017). Of the total participants, 99 had anxiety (42.3%), 136 had depression (58.1%), and 66 had (28.2%) comorbid anxiety-depression. Multivariate analysis was used. For anxiety age, female gender, smoking, diabetes mellitus, and 2 or more chronic diseases had a significant association. For depression, age and diabetes mellitus had a significant association, and for comorbid anxiety, depression, age, diabetes mellitus, and 2 or more chronic diseases had a significant association. Conclusion. This study shows that anxiety and depression are highly prevalent among hypertensive patients in an outpatient clinic in Afghanistan. There was an association between some sociodemographic and clinical characteristics and anxiety and depression. More studies are needed on a national level to inform the development of strategies for the prevention and control of psychological distress among patients with chronic diseases in Afghanistan.

Download Full-text

Factor Structure of the Mood and Anxiety Symptom Questionnaire does not Generalize to an Anxious/Depressed Sample

Australian & New Zealand Journal of Psychiatry ◽

10.1080/j.1440-1614.2006.01926.x ◽

2006 ◽

Vol 40 (11-12) ◽

pp. 1016-1024 ◽

Cited By ~ 16

Author(s):

Mark J Boschen ◽

Tian P.S. Oei

Keyword(s):

Factor Structure ◽

Anxiety Symptom ◽

Clinical Sample ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Tripartite Model ◽

Unit Of Analysis ◽

Symptom Questionnaire ◽

Confirmatory Factor ◽

Anxiety Depression

Objective: The tripartite model of anxiety and depression has been proposed as a representation of the structure of anxiety and depression symptoms. The Mood and Anxiety Symptom Questionnaire (MASQ) has been put forwards as a valid measure of the tripartite model of anxiety and depression symptoms. This research set out to examine the factor structure of anxiety and depression symptoms in a clinical sample to assess the MASQ's validity for use in this population. Method: The present study uses confirmatory factor analytic methods to examine the psychometric properties of the MASQ in 470 outpatients with anxiety and mood disorder. Results: The results showed that none of the previously reported two-factor, three-factor or five-factor models adequately fit the data, irrespective of whether items or subscales were used as the unit of analysis. Conclusion: It was concluded that the factor structure of the MASQ in a mixed anxiety/ depression clinical sample does not support a structure consistent with the tripartite model. This suggests that researchers using the MASQ with anxious/depressed individuals should be mindful of the instrument's psychometric limitations.

Download Full-text

Effectiveness and Safety of Xinkeshu Tablet (XKS) on Coronary Heart Disease Patients Combined with Anxiety and Depression Symptoms After Percutaneous Coronary Intervention: A Protocol for Systematic Review and Meta-Analysis

10.21203/rs.3.rs-44377/v1 ◽

2020 ◽

Author(s):

Mingtai Chen ◽

Yingnan Chen ◽

Ling Men ◽

Xiaoling Zhong ◽

Shudong Yang ◽

...

Keyword(s):

Systematic Review ◽

Coronary Heart Disease ◽

Percutaneous Coronary Intervention ◽

Meta Analysis ◽

Depression Scale ◽

Coronary Intervention ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Percutaneous Coronary ◽

Anxiety Depression

Abstract Backgroud: It’s known that coronary heart disease (CHD) patients after percutaneous coronary intervention (PCI) was significantly associated with anxiety and depression symptoms. Several studies have showed that Xinkeshu tablet (XKS), a kind of Chinese herbal medicine (CHM) , could effectively improve post-PCI postoperative mood disorders in CHD patients. However, the intensity of evidence has been poor, limiting the further clinical application of XKS to patients above. This systematic review and meta-analysis will assess studies of the effectiveness and safety of XKS in CHD patients with anxiety and depression symptoms after PCI. Methods: A systematic literature search for articles up to July 2020 will be performed in following electronic databases: PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP) Database, Chinese Biomedical Database (CBM), Chinese Biomedical Literature Service System (SinoMed) and Wanfang Database. Inclusion criteria are randomized controlled trials of XKS applied on patients with CHD and depression. The primary outcome measures will be CHD-related clinical evaluation (frequency of acute attack angina, severity of angina pectoris, electrocardiographic changes, amount of nitroglycerin) and the scores or reducing fractions of depressive and anxiety measuring scales (the Hospital Anxiety / Depression Scale or other widely used anxiety / depression scale). The safety outcome measures will be adverse events, liver and kidney function. RevMan 5.3 software will be used for data synthesis, sensitivity analysis, subgroup analysis and risk of bias assessment. A funnel plot will be developed to evaluate reporting bias. Stata 12.0 will be used for meta-regression and Egger tests. We will use the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to assess the quality of evidence. Discussion: This study will provide a high-quality synthesis of the effects and safety of XKS for CHD patients with anxiety and depression symptoms after PCI. Ethics and dissemination This systematic review does not require ethics approval and will be submitted to a peer-reviewed journal. Trial registration number PROSPERO CRD42019131346.

Download Full-text

Anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator according to gender and age

Rev Rene ◽

10.15253/2175-6783.20212261117 ◽

2021 ◽

Vol 22 ◽

pp. e61117

Author(s):

Isabelle Brigliadori Ignácio ◽

Paolla Algarte Fernandes ◽

Suellen Rodrigues de Oliveira Maier ◽

Carina Aparecida Marost Dessotte

Keyword(s):

Implantable Cardioverter Defibrillator ◽

Statistical Significance ◽

University Hospital ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Cross Sectional ◽

Cardioverter Defibrillator ◽

Cardiac Anxiety ◽

Gender And Age ◽

Anxiety Depression

Objective: to investigate the relationship between gender and age with symptoms of anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator. Methods: cross-sectional study, with 76 patients with device attended in a university hospital. For data collection, a sociodemographic/clinical form and two validated scales were used in Brazil. In the analysis, the chi-square tests, exact Fischer and Mann-Whitney, with a significance level of 5% were adopted. Results: it was observed that the groups were homogeneous in terms of gender and age. Women presented higher medians in both anxiety and depression symptoms, with statistical significance. They also presented higher medians in symptoms of cardiac anxiety, but without statistical significance. Regarding age, no significant differences were found for the symptoms investigated. Conclusion: women presented more symptoms of anxiety and depression; however there was no relationship between the age of the patients and their symptoms.

Download Full-text

Cost-effectiveness of WHO Problem Management Plus for adults with mood and anxiety disorders in a post-conflict area of Pakistan: randomised controlled trial

The British Journal of Psychiatry ◽

10.1192/bjp.2020.138 ◽

2020 ◽

Vol 217 (5) ◽

pp. 623-629 ◽

Cited By ~ 2

Author(s):

Syed Usman Hamdani ◽

Zill-e- Huma ◽

Atif Rahman ◽

Duolao Wang ◽

Tao Chen ◽

...

Keyword(s):

Cost Effectiveness ◽

Depression Scale ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Problem Management ◽

Post Conflict ◽

Intervention Cost ◽

The Mean ◽

The Cost ◽

Anxiety Depression

BackgroundWith the development of evidence-based interventions for treatment of priority mental health conditions in humanitarian settings, it is important to establish the cost-effectiveness of such interventions to enable their scale-up.AimsTo evaluate the cost-effectiveness of the Problem Management Plus (PM+) intervention compared with enhanced usual care (EUC) for common mental disorders in primary healthcare in Peshawar, Pakistan. Trial registration ACTRN12614001235695 (anzctr.org.au).MethodWe randomly allocated 346 participants to either PM+ (n = 172) or EUC (n = 174). Effectiveness was measured using the Hospital Anxiety and Depression Scale (HADS) at 3 months post-intervention. Cost-effectiveness analysis was performed as incremental costs (measured in Pakistani rupees, PKR) per unit change in anxiety, depression and functioning scores.ResultsThe total cost of delivering PM+ per participant was estimated at PKR 16 967 (US$163.14) using an international trainer and supervisor, and PKR 3645 (US$35.04) employing a local trainer. The mean cost per unit score improvement in anxiety and depression symptoms on the HADS was PKR 2957 (95% CI 2262–4029) (US$28) with an international trainer/supervisor and PKR 588 (95% CI 434–820) (US$6) with a local trainer/supervisor. The mean incremental cost-effectiveness ratio (ICER) to successfully treat a case of depression (PHQ-9 ≥ 10) using an international supervisor was PKR 53 770 (95% CI 39 394–77 399) (US$517), compared with PKR 10 705 (95% CI 7731–15 627) (US$102.93) using a local supervisor.ConclusionsThe PM+ intervention was more effective but also more costly than EUC in reducing symptoms of anxiety, depression and improving functioning in adults impaired by psychological distress in a post-conflict setting of Pakistan.

Download Full-text

Benefits of EEG-Neurofeedback on the Modulation of Impulsivity in a Sample of Cocaine and Heroin Long-Term Abstinent Inmates: A Pilot Study

International Journal of Offender Therapy and Comparative Criminology ◽

10.1177/0306624x20904704 ◽

2020 ◽

Vol 64 (12) ◽

pp. 1275-1298

Author(s):

M. Corominas-Roso ◽

I. Ibern ◽

M. Capdevila ◽

R. Ramon ◽

C. Roncero ◽

...

Keyword(s):

Pilot Study ◽

Clinical Improvement ◽

Rating Scale ◽

Treated Group ◽

Small Sample ◽

Anxiety And Depression ◽

Control Group ◽

Potential Range ◽

Significant Clinical Improvement

The aim of this pilot study was to assess whether neurofeedback (NFB) can be useful in the treatment of impulsive behavior in long-term abstinent cocaine and heroin addicts. A single-blind sham-controlled NFB protocol was carried out to assess the effects of NFB on impulsivity in 20 (10 + 10) cocaine and heroin long-term abstinent addicts ( Diagnostic and Statistical Manual of Mental Disorders [4th ed., text rev.; DSM-IV-TR]). Psychotic and neurologic diseases were excluded. Participants underwent 40 NFB sessions based on the very slow cortical potential range. Inhibitory deficits were specifically addressed through right and left prefrontal training. Clinical improvement was measured with Likert-type scales, the Hamilton Depression Rating Scale, and the State–Trait Anxiety Inventory, and impulsivity was assessed using the Barratt Impulsiveness Scale and the Continuous Performance Test. Although the results are preliminary due to the small sample size, the NFB-treated group showed a significant clinical improvement, including symptoms of anxiety and depression, with two differentiated time periods. No significant clinical improvement was found in the control group. A significant decrease in the post- versus pre-treatment measures of global impulsivity, nonplanning impulsivity, and error commission measures was found in the NFB-treated group; effect size ( dKorr) in the pre–post control design was moderate. No significant change was found in the control group. Despite the limitations of this study, the results suggest that NFB is better than placebo in improving impulsivity and clinical symptoms of anxiety and depression in long-term abstinent cocaine- and heroin-dependent individuals.

Download Full-text

Problematic Smartphone Use and Mental Health in Chinese Adults: A Population-Based Study

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph17030844 ◽

2020 ◽

Vol 17 (3) ◽

pp. 844 ◽

Cited By ~ 5

Author(s):

Ningyuan Guo ◽

Tzu Tsun Luk ◽

Sai Yin Ho ◽

Jung Jae Lee ◽

Chen Shen ◽

...

Keyword(s):

Symptom Severity ◽

Well Being ◽

Anxiety And Depression ◽

Smartphone Addiction ◽

Depression Symptoms ◽

Chinese Adults ◽

Problematic Smartphone Use ◽

Smartphone Use ◽

Anxiety Depression ◽

Mental Well Being

Problematic smartphone use (PSU) has been associated with anxiety and depression, but few explored its mental well-being correlates that could co-occur with or be independent of mental symptoms. We studied the associations of PSU with anxiety, depression, and mental well-being in Hong Kong Chinese adults in a probability-based survey (N = 4054; 55.0% females; mean age ± SD 48.3 ± 18.3 years). PSU was measured using Smartphone Addiction Scale-Short Version. Anxiety and depression symptoms were evaluated using General Anxiety Disorder screener-2 (GAD-2) and Patient Health Questionnaire-2 (PHQ-2). Mental well-being was measured using Subjective Happiness Scale (SHS) and Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS). Multivariable regression analyzed associations adjusting for sociodemographic and lifestyle-related variables. Associations of PSU with mental well-being were stratified by symptom severity of anxiety (GAD-2 cutoff of 3) and depression (PHQ-2 cutoff of 3). We found that PSU was associated with higher odds of anxiety and depression symptom severity and lower scores of SHS and SWEMWBS. Associations of PSU with lower SHS and SWEMWBS scores remained in respondents who screened negative for anxiety or depression symptoms. To conclude, PSU was associated with anxiety, depression, and impaired mental well-being. Associations of PSU with impaired mental well-being could be independent of anxiety or depression symptoms.

Download Full-text

Association between anxiety and depression symptoms with resistant hypertension and central hemodynamics: A pilot study

Hellenic Journal of Cardiology ◽

10.1016/j.hjc.2016.07.004 ◽

2016 ◽

Vol 57 (3) ◽

pp. 203-204 ◽

Cited By ~ 5

Author(s):

A. Mermerelis ◽

S.-M. Kyvelou ◽

A. Vellinga ◽

C. Papageorgiou ◽

C. Stefanadis ◽

...

Keyword(s):

Pilot Study ◽

Resistant Hypertension ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Central Hemodynamics

Download Full-text

An Empirical Assessment of REBT Models of Psychopathology and Psychological Health in the Prediction of Anxiety and Depression Symptoms

Behavioural and Cognitive Psychotherapy ◽

10.1017/s1352465817000133 ◽

2017 ◽

Vol 45 (6) ◽

pp. 600-615 ◽

Cited By ~ 16

Author(s):

Horea-Radu Oltean ◽

Philip Hyland ◽

Frédérique Vallières ◽

Daniel Ovidiu David

Keyword(s):

Root Mean Square ◽

Psychological Health ◽

Structural Equation ◽

Irrational Beliefs ◽

Satisfaction With Life ◽

Well Being ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Mean Square ◽

Anxiety Depression

Aims: This study aimed to assess the validity of two models which integrate the cognitive (satisfaction with life) and affective (symptoms of anxiety and depression) aspects of subjective well-being within the framework of rational emotive behaviour therapy (REBT) theory; specifically REBT's theory of psychopathology and theory of psychological health. Method: 397 Irish and Northern Irish undergraduate students completed measures of rational/irrational beliefs, satisfaction with life, and anxiety/depression symptoms. Structural equation modelling techniques were used in order to test our hypothesis within a cross-sectional design. Results: REBT's theory of psychopathology (χ2 = 373.78, d.f. = 163, p < .001; comparative fit index (CFI) = .92; Tucker Lewis index (TLI) = .91; root mean square error of approximation (RMSEA) = .06 (95% CI = .05 to .07); standardized root mean square residual (SRMR) = .07) and psychological health (χ2 = 371.89, d.f. = 181, p < .001; CFI = .93; TLI = .92; RMSEA = .05 (95% CI = .04 to .06); SRMR = .06) provided acceptable fit of the data. Moreover, the psychopathology model explained 34% of variance in levels of anxiety/depression, while the psychological health model explained 33% of variance. Conclusions: This study provides important findings linking the fields of clinical and positive psychology within a comprehensible framework for both researchers and clinicians. Findings are discussed in relation to the possibility of more effective interventions, incorporating and targeting not only negative outcomes, but also positive concepts within the same model.

Download Full-text

MINDFULNESS TRAINING FOR CAREGIVERS OF ALZHEIMER PATIENTS: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Innovation in Aging ◽

10.1093/geroni/igz038.3159 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

pp. S860-S860

Author(s):

Miriam Hurtado Pomares ◽

Daniel Mendialdua Canales ◽

Paula Peral Gómez ◽

Cristina Espinosa Sempere ◽

Iris Juárez Leal ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Pilot Study ◽

Controlled Trial ◽

Neuropsychiatric Symptoms ◽

Depression Scale ◽

Neuropsychiatric Disorders ◽

Anxiety And Depression ◽

Control Group ◽

Depression Symptoms ◽

Randomized Controlled

Abstract Mindfulness Based Health Care (MBHC) provides meditation techniques that may help to mitigate negative impact of dementia caregiving. We conducted a pilot randomized controlled trial with two parallel groups including 42 caregivers of Alzheimer patients (21 pairs). MBHC group learned the practice of mindfulness meditation once a week through 8 classes; control group did not receive any therapy. Anxiety and depression symptoms were the primary outcomes assessed in two occasions, i.e. at baseline and the end of the program, using the Hospital Anxiety and Depression scale respectively. Neuropsychiatric disorders of Alzheimer patients were also measured with Neuropsychiatric Inventory-Questionnaire. The details of the randomized controlled trial were described in clinicaltrial.gov NCT03858283. In this abstract, we presented the results of a pilot study conducted with 42 caregivers. Robust linear regression using MM-type estimator was performed to evaluate the changes in neuropsychiatric disorders in patients and anxiety and depression symptoms in caregivers adjusting for Score of Scale Global Deterioration. We observed that, compared to the control group, the MBHC group showed a tendency to a reduction in the total score Neuropsychiatric Inventor (β=-5.20; CI 95%: -10.47; 0.07) and the depression symptoms in the caregivers (β=-2.30; CI 95%: -5.43; 0.83). However, no changes were observed in the anxiety symptoms of the caregivers. In conclusion, the results of this pilot study suggested a positive effective on the reduction of neuropsychiatric symptoms in patents as well as on the depression in the caregivers. Nevertheless, these findings should be confirmed in a further complete study.

Download Full-text